HomeArticles | Case Reports | Supplements | Podcast Episodes | Translational Videos

 

JDD Special Focus

Psoriasis Podcast Episodes

What Women Don’t Want … Psoriasis

In this edition of the JDD Podcast, Dr. Adam Friedman is joined by Dr. Deirdre Hooper, Associate Clinical Professor in the Department of Dermatology at both Louisiana State University and Tulane University, to discuss her article “Impact of Psoriasis on Women” in the September 2019 issue of the JDD on the unique considerations for the adult female psoriasis patient.

What questions should you be asking? What matters most when discussing therapeutic options? What is the best way to partner to ensure a long term relationship? If we could read minds this podcast would not be necessary but alas, it sorely is. Check it out!

Picking up on Prescribing Patterns for Psoriasis: A Real Deal Assessment

We (and our patients) are fortunate to live during a time when we have many safe and effective options to treat a chronic inflammatory skin disease such as Psoriasis. We are reminded of this, nay inundated, with warm and fuzzy headlines in the lay dermatology press that humblebrag said efficacy. However, how does this translate to the real world, when the perfect, neat lines of clinical trials are blurred by practical issues such as access, patient and practitioner perception, and long term use and efficacy? In a JDD Podcast first, we had not one but two investigators share their work and first steps to evaluate just that.

Sponsored

To Treat or Not To Treat: Systemic Therapy Considerations for Psoriasis in the Setting of Malignancy

I’m a biologic girl in a biologic world…or so I think myself and never say out loud when reviewing therapeutic options for moderate to severe psoriasis. We are so fortunate to have so many wonderful options, however certain clinical scenarios may limit our ability to capitalize on said armament mostly due to limited experience and data. Enter previous malignancy – in most phase 3 studies these patients are weeded out or the history of malignancy must be at least 5 years prior to entry. So what to do? Our colleagues at Tufts Medical Center asked this very question. Tune in to hear what Dr. David Rosmarin, Assistant Professor of Dermatology and Residency Program Director learned from performing a retrospective chart review and how his work and his experience guides his clinical decision making when managing psoriasis. Don’t flake (or is it scale?)…check it out.

Ask the Investigator: Shedding Some Light on Phototherapy Protocols for Psoriasis and Tips to Improve Patient Screening and Treatment

In this edition of the JDD Podcast, Dr. Adam Friedman reviews phototherapy protocols and pearls with psoriasis expert Dr. Jashin Wu, Director of Research at Kaiser Permanente based on his study published in the August 2016 Journal of Drugs in Dermatology titled “Comparison of Phototherapy Guidelines for Psoriasis: A Critical Appraisal and Comprehensive Review.” Also tune in to hear how Dr. Wu counsels his psoriasis patients on psoriasis comorbidities and initiates, and manages them with phototherapy, topicals, and systemic immunosuppressants.

Sponsored

Translational Lecture Series

Targeting cAMP Signaling for the Treatment of Inflammatory Diseases of the Skin

Dr. Jon Zippin, Assistant Attending Dermatologist and Assistant Professor of Dermatology at Weill Medical College of Cornell, elucidates the complexity of cAMP biology and the translational impact of PDE4 inhibition as it relates to chronic inflammatory skin diseases. Tune in to learn why targeting this pathway is clinically meaningful but also where more work is needed to improve outcomes.

Psoriasis: Biological Basis for Comorbidities

Dr. Abrar Qureshi, Professor and Chair of Department of Dermatology at The Warren Alpert Medical School of Brown University, reviews his research to uncover the biological basis for many of the co-morbidities associated with, and risk factors for, psoriasis. Through this clear and clinically oriented presentation, the common pathophysiological threads are elucidated with a focus on identifying preventive strategies and therapeutic targets for current and future treatments.

HomeArticles | Case Reports | Supplements | Podcast Episodes | Translational Videos

Dermatology News

Acne Vulgaris Treatment Falls ShortFeatured ArticlesHome page featureThe Latest
June 9, 2021

Acne Vulgaris Treatment Falls Short

The majority of acne patients are not likely to achieve success according to FDA guidance. Is the FDA guidance too rigorous? Luciana Nofal What is the likelihood of treatment success…
Wildfires and EczemaDermatology RoundupJDD HighlightsThe Latest
June 2, 2021

Wildfires & Eczema, Botulinum Toxin & Depression, Mentor Award

A recent study found short-term exposure to wildfire-associated air pollution appears to exacerbate atopic dermatitis and itch. Dermatology Roundup Allison Sit A recent study found short-term exposure to wildfire-associated air…
JDD Impact Factor and InfluenceJDD HighlightsJDD in the MediaThe Latest
May 26, 2021

JDD in the News: Chlorophyll for Clear Skin, Depression & Isotretinoin

The Journal of Drugs in Dermatology is featured in two recent articles about the latest TikTok trend -- chlorophyll. The Journal of Drugs in Dermatology in the News  Allison Sit…
Neutrogena Face Sunscreen Suncare for AllJDD HighlightsJDD Webinars
May 10, 2021

Suncare for All: New Insights and Solutions for Protecting Patients of All Skin Tones

Supported By   Watch an important discussion with thought leaders in dermatology, behavioral science and sunscreen innovation, including new original research on multicultural beliefs and challenges in photoprotection. Faculty Shirley…